Bollard Group LLC
Source: SEC Form 13F · as of Mar 2026Bollard Group LLC holds 22 biotech & pharma companies tracked by BioSniper, totaling $247K in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$247K
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 190,672 | $175K |
| MRKMerck & Co., Inc. | 138,765 | $17K |
| JNJJOHNSON & JOHNSON | 55,723 | $14K |
| PMPhilip Morris International Inc | 61,234 | $10K |
| TECXTectonic Therapeutic, Inc. | 302,953 | $9K |
| ABTABBOTT LABORATORIES | 79,773 | $8K |
| BMYBRISTOL MYERS SQUIBB CO | 115,000 | $7K |
| ACRSAclaris Therapeutics, Inc. | 431,631 | $2K |
| AMGNAMGEN INC | 4,087 | $1K |
| PRMEPrime Medicine, Inc. | 361,136 | $1K |
| CORCencora Inc. | 2,241 | $704 |
| ABBVAbbVie Inc. | 2,195 | $477 |
| VORVor Biopharma Inc. | 23,987 | $428 |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 686 | $186 |
| IQVIQVIA Holdings Inc. | 911 | $155 |
| MCKMcKesson Corporation | 87 | $75 |
| AZNASTRAZENECA PLC | 277 | $55 |
| GMOptec International, Inc. | 241 | $18 |
| GEHCGE HealthCare Technologies Inc. | 129 | $9 |
| PFEPFIZER INC | 68 | $2 |
| OGNOrganon & Co. | 184 | $1 |
| VTRSViatris Inc | 30 | $0 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.